1. Home
  2. PHAR vs ESQ Comparison

PHAR vs ESQ Comparison

Compare PHAR & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • ESQ
  • Stock Information
  • Founded
  • PHAR 1988
  • ESQ 2006
  • Country
  • PHAR Netherlands
  • ESQ United States
  • Employees
  • PHAR N/A
  • ESQ N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • PHAR Health Care
  • ESQ Finance
  • Exchange
  • PHAR Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • PHAR 618.3M
  • ESQ 638.2M
  • IPO Year
  • PHAR N/A
  • ESQ 2017
  • Fundamental
  • Price
  • PHAR $8.20
  • ESQ $85.68
  • Analyst Decision
  • PHAR Strong Buy
  • ESQ Hold
  • Analyst Count
  • PHAR 3
  • ESQ 3
  • Target Price
  • PHAR $27.00
  • ESQ $88.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • ESQ 113.9K
  • Earning Date
  • PHAR 03-13-2025
  • ESQ 01-23-2025
  • Dividend Yield
  • PHAR N/A
  • ESQ 0.81%
  • EPS Growth
  • PHAR N/A
  • ESQ 4.68
  • EPS
  • PHAR N/A
  • ESQ 5.14
  • Revenue
  • PHAR $285,745,000.00
  • ESQ $120,124,000.00
  • Revenue This Year
  • PHAR $20.08
  • ESQ N/A
  • Revenue Next Year
  • PHAR $9.22
  • ESQ $10.75
  • P/E Ratio
  • PHAR N/A
  • ESQ $16.70
  • Revenue Growth
  • PHAR 30.64
  • ESQ 10.21
  • 52 Week Low
  • PHAR $6.65
  • ESQ $44.45
  • 52 Week High
  • PHAR $13.20
  • ESQ $90.18
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 36.29
  • ESQ 55.86
  • Support Level
  • PHAR $8.49
  • ESQ $81.10
  • Resistance Level
  • PHAR $9.35
  • ESQ $90.18
  • Average True Range (ATR)
  • PHAR 0.55
  • ESQ 2.94
  • MACD
  • PHAR -0.17
  • ESQ 0.09
  • Stochastic Oscillator
  • PHAR 12.14
  • ESQ 60.95

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.

Share on Social Networks: